Effect of Intrathecal Morphine in Children Undergoing Major Abdominal Surgeries,

NCT ID: NCT03158584

Last Updated: 2017-05-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

45 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-01-01

Study Completion Date

2017-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

safety and efficacy of intrathecal morphine in post operative pain relief in pediatric patients undergoing major abdominal cancer surgeries using different doses of intrathecal morphine (2 μg/kg , 5 μg/kg ,10 μg/kg).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

After obtaining approval of the local ethics committee of faculty of medicine, Assiut University , Assiut , Egypt , and parent's written informed consent, This randomized double -blinded prospective study conducted on ( 45 ) pediatric patients aged 3-12 years , weighting between 10-30 kg , and of American Society of Anesthesiologists (ASA) physical status I and II scheduled for major abdominal surgeries

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Major Abdominal Surgeries

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

morphine 2 μg/kg

Children will receive intrathecal morphine 2 μg/kg in 2 ml volume normal saline.

Group Type ACTIVE_COMPARATOR

Intrathecal Morphine

Intervention Type DRUG

Intrathecal administration of Morphine in children undergoing major abdominal surgeries

morphine 5 μg/kg

Children will receive intrathecal morphine 5 μg/kg in 2 ml volume normal saline.

Group Type ACTIVE_COMPARATOR

Intrathecal Morphine

Intervention Type DRUG

Intrathecal administration of Morphine in children undergoing major abdominal surgeries

morphine 10 μg/kg

Children will receive intrathecal morphine 10 μg/kg in 2 ml volume normal saline.

Group Type ACTIVE_COMPARATOR

Intrathecal Morphine

Intervention Type DRUG

Intrathecal administration of Morphine in children undergoing major abdominal surgeries

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intrathecal Morphine

Intrathecal administration of Morphine in children undergoing major abdominal surgeries

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

morphine sulphate

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* weight between 10-30 kg ,
* American Society of Anesthesiologists (ASA) I - II
* major abdominal surgeries

Exclusion Criteria

* Children with sacral bone abnormalities
* spina bifida
* coagulopathy
* mental delay or retardation
Minimum Eligible Age

3 Years

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sahar Abdel Baky Mohamed

Assistant Professor of Anesthesia,Intensive care and Pain relief

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sahar A Mohamed, MD

Role: PRINCIPAL_INVESTIGATOR

south egypt cancer instutite

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

South Egypt Cancer Institute

Asyut, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

343

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Morphine or Ketamine for Analgesia
NCT06835504 NOT_YET_RECRUITING PHASE3
Morphine PK Subgroup Analysis
NCT01322191 COMPLETED PHASE4
Safety and Efficacy Evaluation of S (+) - Ketamine in Children
NCT04834427 ENROLLING_BY_INVITATION PHASE4